Related Experiment Video
Updated: May 10, 2026

Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments
Published on: May 9, 2019
[The changes in bone geometric parameters by medication]
Junichi Takada1, Kousuke Iba, Toshihiko Yamashita
1Dept. of Orthopaedic Surgery, Sapporo Medical University, Japan.
Insights
Certain osteoporosis medications significantly improve bone strength more than bone density, particularly in the hip region. These findings offer insights into optimizing fracture prevention strategies through targeted bone geometry improvements.
Area of Science:
- Orthopedics and Bone Metabolism
- Pharmacology
- Biomechanical Engineering
Context:
- Osteoporosis treatment aims to reduce fracture risk by improving bone strength.
- Hip structure analysis (HSA) provides detailed geometric bone parameters.
- Understanding medication effects on bone geometry is crucial for treatment selection.
Purpose:
- To review and compare the effects of various osteoporosis medications on bone geometric parameters, specifically hip structure analysis (HSA).
- To evaluate how different drugs influence bone strength indices like section modulus compared to bone mineral density.
Summary:
- Raloxifene, bisphosphonates (alendronate, risedronate, minodronate), and denosumab enhanced section modulus (a measure of bending strength) more effectively than bone mineral density, with greater effects in the intertrochanteric region compared to the femoral neck.
- Teriparatide (20μg/day) showed a different pattern, with similar improvements in section modulus and bone mineral density, and no greater effect in the intertrochanter than the femoral neck.
- Femoral shaft parameters showed less significant changes with these medications, except for a similar tendency to change as the proximal femur with bisphosphonates, raloxifene, and denosumab.
Impact:
- These findings highlight that certain medications improve bone strength (section modulus) more than bone density, suggesting a more direct impact on fracture resistance.
- The differential effects of medications on various hip regions (intertrochanter vs. femoral neck) can inform personalized treatment strategies for osteoporosis.
- This review provides valuable data for clinicians and researchers in selecting therapies that optimize biomechanical bone properties for fracture prevention.
Abstract:
The changes in bone geometric parameters (hip structure analysis, HSA) by medication are reviewed. HSA parameters are strongly correlated with CT parameters. Raloxifene, bisphosphonate (alendronate, risedronate, minodronate) , and denosumab improved section modulus (index for bending force) more than bone mineral density, and the improvements in section modulus are superior in intertrochanter than in femoral neck. The tendency to change in femoral shaft is approximately similar in femoral neck and intertrochanter. On the other hand, the tendency to change in these parameters in teriparatide (20μg/day) is different from raloxifene, bisphosphonate, and denosumab. Teriparatide improved section modulus and bone mineral density in femoral neck and intertrochanter, but the improvement in section modulus was approximately similar in bone mineral density and the improvement in intertrochanter is not higher than femoral neck. The femoral shaft did not show significant change.
More Related Videos
04:20Practical Considerations for the Design, Execution, and Interpretation of Studies Involving Whole-Bone Bending Tests of Rodent Bones
Published on: September 1, 2023
05:25Using Inducible Osteoblastic Lineage-Specific Stat3 Knockout Mice to Study Alveolar Bone Remodeling During Orthodontic Tooth Movement
Published on: July 21, 2023
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling and Repair
Osteoclasts in Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...